Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Side effect management of old and new anti-tumour agents: ESMO Guidelines into practice

Updates in oncological emergencies

Date

20 Nov 2020

Session

Side effect management of old and new anti-tumour agents: ESMO Guidelines into practice

Topics

Management of Systemic Therapy Toxicities; Supportive Care and Symptom Management

Tumour Site

Presenters

Alexandre Chan

Authors

A. Chan

Author affiliations

Pharmacy, University of California, Irvine School of Medicine, 92617 - Irvine/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

20 Nov 2020

Checkpoint inhibitors: How to manage rare and life threatening irAE

Presenter: Christina Ruhlmann

Session: Side effect management of old and new anti-tumour agents: ESMO Guidelines into practice

Resources:

Slides

Webcast

20 Nov 2020

Acute toxicity: Side-effect management of conventional chemotherapeutic agents

Presenter: Florian Scotté

Session: Side effect management of old and new anti-tumour agents: ESMO Guidelines into practice

Resources:

Slides

Webcast

20 Nov 2020

LIVE Q&A

Presenter: Alexandre Chan

Session: Side effect management of old and new anti-tumour agents: ESMO Guidelines into practice

Resources:

Webcast